Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, May 10th:
Compania Cervecerias Unidas S.A. (CCU - Free Report) : The beverage company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 16.5% over the last 60 days.
Compania Cervecerias Unidas’s shares gained 10.1% over the last three months higher than S&P 500’s gains of 3.9%. The company possesses a Momentum Score of A.
Grand Canyon Education, Inc. (LOPE - Free Report) : The postsecondary education services provider has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 5.2% over the last 60 days.
Grand Canyon Education’s shares gained 36.8% over the last three months. The company possesses a Momentum Score of A.
Bioverativ Inc. : The biotechnology companyhas a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.8% over the last 60 days.
Bioverativ’s shares gained 32% over the last three months higher. The company possesses a Momentum Score of A.
Humana Inc. (HUM - Free Report) : The health services companyhas a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 1.5% over the last 60 days.
Humana’s shares gained 11.4% over the last three months. The company possesses a Momentum Score of A.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here
Now See All Our Private Trades
While today's Zacks Rank #1 new additions are being shared with the public, other trades are hidden from everyone but selected members. Would you like to peek behind the curtain and view them? Starting today, for the next month, you can follow all Zacks' private buys and sells in real time from value to momentum . . . from stocks under $10 to ETF and option moves . . . from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors. Click here for all Zacks trades >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, May 10th:
Compania Cervecerias Unidas S.A. (CCU - Free Report) : The beverage company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 16.5% over the last 60 days.
Compania Cervecerias Unidas’s shares gained 10.1% over the last three months higher than S&P 500’s gains of 3.9%. The company possesses a Momentum Score of A.
Grand Canyon Education, Inc. (LOPE - Free Report) : The postsecondary education services provider has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 5.2% over the last 60 days.
Grand Canyon Education’s shares gained 36.8% over the last three months. The company possesses a Momentum Score of A.
Bioverativ Inc. : The biotechnology companyhas a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.8% over the last 60 days.
Bioverativ’s shares gained 32% over the last three months higher. The company possesses a Momentum Score of A.
Humana Inc. (HUM - Free Report) : The health services companyhas a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 1.5% over the last 60 days.
Humana’s shares gained 11.4% over the last three months. The company possesses a Momentum Score of A.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here
Now See All Our Private Trades
While today's Zacks Rank #1 new additions are being shared with the public, other trades are hidden from everyone but selected members. Would you like to peek behind the curtain and view them? Starting today, for the next month, you can follow all Zacks' private buys and sells in real time from value to momentum . . . from stocks under $10 to ETF and option moves . . . from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors. Click here for all Zacks trades >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on HUM - FREE
Get the latest research report on LOPE - FREE
Get the latest research report on CCU - FREE